Facilitation to Increase Tobacco Treatment

by palligoelme@gmail.com | Mar 6, 2026 | Clinical Trials

​ Conditions: Serious Mental Illness; Tobacco Use Disorder Interventions: Other: Multi-component facilitation Sponsors: VA Office of Research and Development Not yet recruiting Conditions: Serious Mental Illness; Tobacco Use Disorder Interventions: Other:...

ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in Adolescence

by palligoelme@gmail.com | Mar 6, 2026 | Clinical Trials

​ Conditions: Social Anxiety Disorder (SAD); Oppositional Defiant Disorder Interventions: Behavioral: ACTsocially Sponsors: University of Coimbra; Foundation for Science and Technology, Portugal Recruiting Conditions: Social Anxiety Disorder (SAD); Oppositional...

Closed-loop Response to Unannounced Mixed and Carbohydrates-rich Breakfasts

by palligoelme@gmail.com | Mar 6, 2026 | Clinical Trials

​ Conditions: Type 1 Diabetes Mellitus Interventions: Other: Unannounced meal Sponsors: University of Catania Completed Conditions: Type 1 Diabetes Mellitus Interventions: Other: Unannounced meal Sponsors: University of Catania...

Plant miRNAs In Human Plasma After Broccoli Consumption

by palligoelme@gmail.com | Mar 6, 2026 | Clinical Trials

​ Conditions: Healthy Interventions: Dietary Supplement: Broccoli consumption Sponsors: IMDEA Food Completed Conditions: Healthy Interventions: Dietary Supplement: Broccoli consumption Sponsors: IMDEA Food Completed 

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

by palligoelme@gmail.com | Mar 6, 2026 | Clinical Trials

​ Conditions: Narcolepsy Type 1 Interventions: Drug: ALKS 2680 Dose 1; Drug: ALKS 2680 Dose 2; Drug: Placebo Sponsors: Alkermes, Inc. Not yet recruiting Conditions: Narcolepsy Type 1 Interventions: Drug: ALKS 2680 Dose 1; Drug: ALKS 2680 Dose 2; Drug: Placebo...

Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.

by palligoelme@gmail.com | Mar 6, 2026 | Clinical Trials

​ Conditions: Anxiety; Depression – Major Depressive Disorder; Bipolar; Schizophenia Disorder Sponsors: Shalvata Mental Health Center; University Hospital, Antwerp; San Raffaele University Hospital, Italy; Oslo University Hospital Active, not...